Univ. Grenoble Alpes, AGEIS, Grenoble, France.
Grenoble Alpes University Hospital, Grenoble, France.
Curr Rheumatol Rev. 2022;18(2):117-123. doi: 10.2174/1573397117666210921114949.
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease predominantly affecting the axial skeleton. axSpA includes radiographic (i.e., ankylosing spondylitis (AS)) and non-radiographic forms (nr-axSpA). Although recent studies have reported that patients with AS have impaired gait, axSpA's consequences on gait remain unknown. The present review's objectives were to identify: 1) how gait is assessed in patients with axSpA, and 2) what the gait characteristics are of patients with axSpA. This systematic review's protocol was registered in the Prospero database (CRD42020128509). Three databases were systematically searched using keywords related to axSpA and gait. Two independent reviewers selected the articles and extracted the data. The search revealed two hundred titles and abstracts, and two articles were finally included in this review, comprising a total of 132 patients with axSpA. One of the included studies used the 6 m maximum gait velocity test (axSpA: 2.2 ± 0.5 m/s), and the other used the six-minute walk test (axSpA: 414 ± 106 m). Neither study involved a control group to compare gait. Only two published studies assessed the gait performance of patients with axSpA using clinical tests. Furthermore, neither of them compared gait performance to healthy controls or differentiated gait between the AS and nr-axSpA forms of axSPA. The present literature review highlights the need for future research to learn more about how gait is impaired in different types of patients with axSpA.
中轴型脊柱关节炎(axSpA)是一种主要影响中轴骨骼的慢性炎症性疾病。axSpA 包括放射学(即强直性脊柱炎(AS))和非放射学形式(nr-axSpA)。尽管最近的研究报告称 AS 患者的步态受损,但 axSpA 对步态的影响仍不清楚。本综述的目的是确定:1)如何评估 axSpA 患者的步态,以及 2)axSpA 患者的步态特征是什么。本系统评价的方案在 Prospero 数据库(CRD42020128509)中进行了注册。使用与 axSpA 和步态相关的关键词,对三个数据库进行了系统搜索。两名独立的审查员选择了文章并提取了数据。检索显示有 200 个标题和摘要,最终有两篇文章被纳入本综述,共包括 132 名 axSpA 患者。其中一项纳入的研究使用了 6 米最大步行速度测试(axSpA:2.2±0.5 m/s),另一项研究使用了 6 分钟步行测试(axSpA:414±106 m)。两项研究均未纳入对照组来比较步态。只有两项已发表的研究使用临床测试评估 axSpA 患者的步态表现。此外,它们都没有将步态表现与健康对照组进行比较,也没有区分 axSpA 的 AS 和 nr-axSpA 形式之间的步态。本文献综述强调需要进一步研究,以了解不同类型的 axSpA 患者的步态是如何受损的。